OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 72 filers reported holding OCULAR THERAPEUTIX INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $74,000 | -26.0% | 14,884 | +4.1% | 0.00% | – |
| Q4 2021 | $100,000 | -2.9% | 14,303 | +38.7% | 0.00% | -100.0% |
| Q3 2021 | $103,000 | +1044.4% | 10,314 | +498.6% | 0.00% | – |
| Q2 2016 | $9,000 | -40.0% | 1,723 | +14.1% | 0.00% | – |
| Q1 2016 | $15,000 | +36.4% | 1,510 | +28.1% | 0.00% | – |
| Q4 2015 | $11,000 | -47.6% | 1,179 | -22.5% | 0.00% | – |
| Q3 2015 | $21,000 | +320.0% | 1,522 | +513.7% | 0.00% | – |
| Q2 2015 | $5,000 | – | 248 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,944,761 | $23,898,000 | 100.00% |
| Opaleye Management Inc. | 5,974,800 | $24,019,000 | 10.83% |
| DELTEC ASSET MANAGEMENT LLC | 2,069,313 | $8,319,000 | 1.95% |
| Kamunting Street Capital Management, L.P. | 275,506 | $1,108,000 | 1.50% |
| Altium Capital Management LP | 695,000 | $2,794,000 | 1.12% |
| Endurant Capital Management LP | 760,228 | $3,056,000 | 1.07% |
| EMERALD ADVISERS, LLC | 1,465,702 | $5,892,000 | 0.30% |
| MSD Partners, L.P. | 1,016,302 | $4,086,000 | 0.25% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,044,732 | $4,200,000 | 0.24% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $781,000 | 0.11% |